← Leaderboards
Elliott Richelson
Mayo Clinic Coll Of Med, Jacksonville
$1,890,005
Attributed
$1,890,005
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $396.4K · FY2006–09$500K$375K$250K$125K$0
'06
'07
'08
'09
Funding mix
By agency
NIH$1,890,005 · 2
By mechanism
R01$1,890,005 · 2
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Coll Of Med, Jacksonville
Same institution · by research overlap
- Beth M Tyler$153,000
Others in their field
Top investigators on “Peptides”
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- John M Lachin · George Washington University$118,672,444
- David Heimbrook · Leidos Biomedical Research, Inc.$91,429,616
- Michael W Weiner · Northern California Institute Res &Educ$78,425,041
- Paul S. Aisen · Cognition Therapeutics, Inc.$69,846,203
- Rolf Apweiler · European Molecular Biology Laboratory$56,677,991
Research focus
PeptidesNeurotensinInjection Of Therapeutic AgentGenerationsAmphetaminesAntischizophrenicDizocilpineBrainAgonistAtypical AntipsychoticAntipsychotic AgentsBehavioralBehavior TestBiochemicalAnimalsAcuteCigarette SmokingApomorphineClinical EffectClozapineCocaineCognitiveBehaviorDose
Grant awards (7)
NT69L: a potential, novel antischizophrenic drug$282,270
R01 · FY2009 · MH · contact PI
NT69L: a potential, novel antischizophrenic drug$282,270
R01 · FY2008 · MH · contact PI
NT69L: a potential, novel antischizophrenic drug$114,152
R01 · FY2008 · MH · contact PI
NT69L: a potential, novel antischizophrenic drug$282,270
R01 · FY2007 · MH · contact PI
NT69L: a potential, novel antischizophrenic drug$282,744
R01 · FY2006 · MH · contact PI
BRAIN AS TARGET FOR ANTISENSE PEPTIDE NUCLEIC ACID DRUGS$327,923
R01 · FY2001 · MH
BRAIN AS TARGET FOR ANTISENSE PEPTIDE NUCLEIC ACID DRUGS$318,376
R01 · FY2000 · MH